Literature DB >> 6324166

cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure.

L Claesson, D Larhammar, L Rask, P A Peterson.   

Abstract

The invariant gamma chain is transitorily associated with class II histocompatibility antigens during intracellular transport. We have isolated and sequenced a cDNA clone corresponding to the human gamma chain. mRNA hybridizing to the cDNA clone translated into a 33,000-dalton chain that associated specifically with class II antigen alpha and beta chains. The gamma chain consists of 216 amino acids. The two N-linked carbohydrates are attached to asparagines 114 and 120. A continuous stretch of hydrophobic and neutral amino acids occurs in positions 31-56 from the NH2 terminus. This region seems to constitute the transmembrane portion of the polypeptide chain. The positions of the carbohydrate moieties and the putative transmembrane segment indicate that the NH2 terminus of the gamma chain resides on the cytoplasmic side of the membrane. Cell-free translations in conjunction with radiochemical amino acid sequence analyses suggest that the gamma chain lacks an NH2-terminal signal sequence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6324166      PMCID: PMC389957          DOI: 10.1073/pnas.80.24.7395

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Purification and mapping of specific mRNAs by hybridization-selection and cell-free translation.

Authors:  R P Ricciardi; J S Miller; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates.

Authors:  P P Jones; D B Murphy; D Hewgill; H O McDevitt
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

Review 3.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

4.  Cell-free synthesis and processing of the heavy and light chains of HLA-DR antigens.

Authors:  A J Korman; H L Ploegh; J F Kaufman; M J Owen; J L Strominger
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 6.  Transfer of proteins across membranes.

Authors:  G Kreil
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

7.  Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.

Authors:  D J Charron; H O McDevitt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

8.  Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II.

Authors:  S J Chan; B E Noyes; K L Agarwal; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Chicken ovalbumin contains an internal signal sequence.

Authors:  V R Lingappa; J R Lingappa; G Blobel
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

Review 10.  Sugar residues on proteins.

Authors:  P V Wagh; O P Bahl
Journal:  CRC Crit Rev Biochem       Date:  1981
View more
  50 in total

1.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 2.  Transport and expression of HLA class-II glycoproteins.

Authors:  P Cresswell; J S Blum; J E Davis; M S Marks
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons.

Authors:  J John; R McKendry; S Pellegrini; D Flavell; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.

Authors:  J van Bergen; S P Schoenberger; F Verreck; R Amons; R Offringa; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

7.  Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation.

Authors:  D M O'Sullivan; D Noonan; V Quaranta
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

8.  Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA.

Authors:  A J McKnight; D W Mason; A N Barclay
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 9.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

10.  Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.

Authors:  G K Hansson; L Jonasson; J Holm; L Claesson-Welsh
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.